Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2018

Jan 18, 2018

34129_dirs_2018-01-18_045ce325-62be-4b95-8fe1-38975752be49.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2018-01-17

Reporting Person: Risser Eric Blasius (Sr VP & Chief Business Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-01-17 Common Stock M 2000 $0.94 Acquired 9100 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-01-17 Employee stock option (right to buy) $0.94 M 2000 Disposed 2019-03-23 Common Stock (2000.0) Direct

Footnotes

F1: This amount includes 1,100 shares purchased through the Company's ESPP; 800 on 5/31/17 and 300 on 11/30/17.